Effect of kisspeptin, neurokinin, and dynorphin neurons on regulation of reproduction.
Racková. Jana J
Key Findings
- KNDy neurons (kisspeptin, neurokinin B, dynorphin) regulate GnRH pulse frequency and amplitude.
- Steroid hormones (estradiol, progesterone, testosterone) provide feedback by acting on KNDy neuron receptors.
- Disruption of KNDy signaling is linked to infertility, PCOS, endometriosis, and menopausal symptoms.
Practical Outcomes
- Understanding KNDy control of GnRH suggests that targeting kisspeptin pathways could modulate reproductive hormone levels. While no direct dosing protocol emerges, biohackers might explore supplements or lifestyle tweaks that influence kisspeptin signaling for fertility or menopausal symptom management, pending further research.
Summary
The brain has special cells called KNDy neurons that release three chemicals—kisspeptin, neurokinin B, and dynorphin—to control the timing and strength of GnRH (gonadorelin) pulses, which drive reproductive hormones. Hormones like estrogen, progesterone, and testosterone can also feed back onto these neurons, affecting puberty, menstrual cycles, and fertility issues.
Abstract
Gonadotropin-releasing hormone pulsatility is under the influence of hypothalamic neuropeptides, especially neurons expressing kisspeptin, neurokinin B, and dynorphin. These hypothalamic cells are called KNDy neurons. By integrating hormonal and environmental stimuli in the brain, they modulate the effects on neuropeptide release and control the frequency and amplitude of pulses. The relationship between KNDy neurons and gonadal hormones is essential for the initiation of puberty, regulation of the menstrual cycle, and reproduction. Steroid hormones have a feedback effect on the modulation of the activity of KNDy neurons, as their membrane and cell nucleus express receptors for estradiol, progesterone, and testosterone. Recent research suggests a close relationship with the pathophysiology of infertility, pathological pregnancy, menstrual cycle disorders, polycystic ovary syndrome, endometriosis, and vasomotor symptoms in perimenopause.
Study Information
pubmed
2025
2025-10-30T00:00:00.000Z
10.48095/cccg2025413